TON - May 2017, Vol 10, No 3

The May issue of The Oncology Nurse-APN/PA (TON) is full of important news and updates for oncology nurses
The H. Lee Moffitt Cancer Center, Tampa, FL, is 1 of 47 National Cancer Institute–designated Comprehensive Care Centers in the United States, and is the only center based in Florida. Care at Moffitt is centered around the patient, and focuses on treating individuals with more common conditions compared with those with rare malignancies.
Androgen deprivation therapy (ADT) for the treatment of prostate cancer has adverse effects that may be difficult for men to tolerate.
Childhood cancer therapy can be a double-edged sword: it often leads to a cure, but long after treatment ends, some cancer survivors are still suffering its side effects.
Adolescents and young adults (AYAs) with cancer often wait too long to discuss their end-of-life preferences, or they do not discuss those preferences at all and pass away in a manner that is against their wishes.
In recognition of the distress associated with the diagnosis and treatment of cancer, the National Comprehensive Cancer Network (NCCN) has produced several resources to help patients report their distress and cope with it.
Following a year in which approximately 2 dozen cancer drugs were approved by the FDA, approvals in 2016 decreased by approximately 50% compared with 2015.
  • Venetoclax plus Rituximab Improves Outcomes in Chronic Lymphocytic Leukemia
  • Lay Navigation Reduces Medicare Costs, Resource Utilization
  • Adding Antiandrogen Therapy Improves Survival in Recurrent Prostate Cancer
The current practice in the treatment of advanced kidney cancer and some other cancers is to continue treatment with immune checkpoint inhibitors until disease progression, and sometimes even longer.
The results of a new study presented at the 2017 Genitourinary Cancers Symposium suggest that recent use of antibiotics may compromise the efficacy of immunotherapy.
Page 1 of 2
Results 1 - 10 of 18